Construction of a prognostic risk model for uveal melanoma based on immune-related long noncoding RNA

Nengqi Lin,Ruohan Lv,Dongliang Yang,Wei Liu

DOI: https://doi.org/10.1097/md.0000000000039385

IF: 1.6

2024-11-08

Medicine

Abstract:In ophthalmic diseases, uveal melanoma (UM) is of great invasion as a highly prevalent malignancy. [ 1 ] Consisting of iris, choroid and ciliary body, the uvea is a mixed layer of blood vessels and nerves located in the middle of the eyeball wall. Statistically, the incidence of UM is 4% in the iris and 6% in the ciliary body, while it is as high as 90% in the choroid. [ 2 ] UM patients have a poor prognosis for survival due to the high malignancy of the tumor. A more recent cohort study of 10,678 samples found the possible lifetime risk of death was 40% to 43%. [ 3 ] However, the lack of the effective prognostic predictor for UM still exists. It has been reported that the progression of UM is strongly associated with G protein-coupled receptor-mediated signaling activation processes, with extensive mutations in genes such as GNAQ, GNA11, and BAP1 in primary UM patients. [ 4–6 ] However, no reports have pointed to a prognostic significance of these mutations. A specific immune segregation (also known as immune privilege) exists in eyes. The ocular microenvironment induces Treg cell production capable of reducing damage to the eye by cellular infiltration in inflammatory cells, while its contents (atrial fluid and vitreous humor) have anti-inflammatory effects. [ 7 ] Uveal melanoma cells may have biological function similar to those normal ocular cells which maintain immune privilege, such as the ability to suppress NK cells through releasing TGF-β or promote T-lymphocyte depletion through the PD-1 pathway, resulting in immune escape. [ 8 ] It is the specific ocular immunological environment that makes it rewarding to improve the prognosis and treatments of UM from an immunological point of view.

medicine, general & internal